Praveen Prakhar
Bengaluru, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pre-existing mycobacterial infection modulates Candida albicans-driven pyroptosis.
Journal: The FEBS journal
Published: January 28, 2021
Correction: Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
Journal: The Journal of biological chemistry
Published: December 15, 2019
Epidermal Growth Factor Receptor-Responsive Indoleamine 2,3-Dioxygenase Confers Immune Homeostasis During Shigella flexneri Infection.
Journal: The Journal of infectious diseases
Published: August 27, 2018
c-Abl-TWIST1 Epigenetically Dysregulate Inflammatory Responses during Mycobacterial Infection by Co-Regulating Bone Morphogenesis Protein and miR27a.
Journal: Frontiers in immunology
Published: August 03, 2017
Aspergillus fumigatus Cell Wall α-(1,3)-Glucan Stimulates Regulatory T-Cell Polarization by Inducing PD-L1 Expression on Human Dendritic Cells.
Journal: The Journal of infectious diseases
Published: April 27, 2017
Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
Journal: The Journal of infectious diseases
Published: February 02, 2017
Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.
Journal: Journal of neuroinflammation
Published: October 27, 2016
MUSASHI-Mediated Expression of JMJD3, a H3K27me3 Demethylase, Is Involved in Foamy Macrophage Generation during Mycobacterial Infection.
Journal: PLoS pathogens
Published: February 15, 2016
Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion.
Journal: Scientific reports
Published: May 30, 2015
Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.
Journal: The Journal of biological chemistry
Published: May 01, 2015
Last Updated: 09/26/2026